摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[3-(quinolin-7-yloxy)propyl]-2,3-dihydro-6,7-methylenedioxy-1,4-benzodioxin-2-methanamine | 151450-57-6

中文名称
——
中文别名
——
英文名称
N-[3-(quinolin-7-yloxy)propyl]-2,3-dihydro-6,7-methylenedioxy-1,4-benzodioxin-2-methanamine
英文别名
N-(6,7-dihydro-[1,3]dioxolo[4,5-g][1,4]benzodioxin-6-ylmethyl)-3-quinolin-7-yloxypropan-1-amine
N-[3-(quinolin-7-yloxy)propyl]-2,3-dihydro-6,7-methylenedioxy-1,4-benzodioxin-2-methanamine化学式
CAS
151450-57-6
化学式
C22H22N2O5
mdl
——
分子量
394.427
InChiKey
SVIQNLDNGHRSSC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    29
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    71.1
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    2,3-Dihydro-6,7-methylenedioxy-1,4-benzodioxin-2-methanamine 、 7-(3-bromopropoxy)quinolineN,N-二异丙基乙胺碘化钠氮气碳酸氢钠氯化钠Sodium sulfate-III 、 silica gel 、 residue 、 乙醇盐酸hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 15.0h, 以to give 1.25 g of the title compound as a yellow solid dihydrochloride salt, m.p. 224°-226° C.的产率得到N-[3-(quinolin-7-yloxy)propyl]-2,3-dihydro-6,7-methylenedioxy-1,4-benzodioxin-2-methanamine
    参考文献:
    名称:
    Antipsychotic quinoline derivatives of benzodioxanmethylamine
    摘要:
    该化合物的化学式为:##STR1## 其中R.sup.1和R.sup.2分别为氢,烷基,烷氧基,芳基烷氧基,脂肪酰氧基,羟基,卤素,氨基,单烷基或二烷基氨基,脂肪酰胺基或磺酰胺基,或R.sup.1和R.sup.2在一起为亚甲二氧基,乙二氧基或丙二氧基; R.sup.3为氢或烷基; n为整数2、3或4; 或其药学上可接受的盐,均为抗精神病药物。
    公开号:
    US05235055A1
点击查看最新优质反应信息

文献信息

  • Antipsychotic quinoline derivatives of benzodioxanmethylamine
    申请人:American Home Products Corporation
    公开号:US05235055A1
    公开(公告)日:1993-08-10
    A compound of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are, independently, hydrogen, alkyl, alkoxy, aralkoxy, alkanoyloxy, hydroxy, halo, amino, mono- or dialkylamino, alkanamido or sulfonamido, or R.sup.1 and R.sup.2 together are methylenedioxy, ethylenedioxy or propylenedioxy; R.sup.3 is hydrogen or alkyl; n is one of the integers 2, 3 or 4; or a pharmaceutically acceptable salt thereof, are antipsychotic agents.
    该化合物的化学式为:##STR1## 其中R.sup.1和R.sup.2分别为氢,烷基,烷氧基,芳基烷氧基,脂肪酰氧基,羟基,卤素,氨基,单烷基或二烷基氨基,脂肪酰胺基或磺酰胺基,或R.sup.1和R.sup.2在一起为亚甲二氧基,乙二氧基或丙二氧基; R.sup.3为氢或烷基; n为整数2、3或4; 或其药学上可接受的盐,均为抗精神病药物。
  • ANTIPSYCHOTIC QUINOLINE DERIVATIVES OF BENZODIOXANMETHYLAMINE
    申请人:AMERICAN HOME PRODUCTS CORPORATION
    公开号:EP0658160A1
    公开(公告)日:1995-06-21
  • Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases
    申请人:Yeadon Michael
    公开号:US20070117788A1
    公开(公告)日:2007-05-24
    The present invention relates to a combination of therapeutic agents useful in the treatment of obstructive airways and other inflammatory diseases comprising (I) a dopamine D2-receptor agonist that is therapeutically effective in the treatment of said diseases when administered by inhalation; together with (II) an anti-cholinergic agent consisting of a member selected from the group consisting of tiotropium and derivatives thereof that is therapeutically effective in the treatment of said diseases when administered by inhalation; as well as to a method of treating said obstructive airways and other inflammatory diseases comprising administering to said mammal by inhalation a therapeutically effective amount of said combination of therapeutic agents; and a pharmaceutical composition comprising a pharmaceutically acceptable carrier together with said combination of therapeutic agents; and a package containing a pharmaceutical composition for insertion into a device capable of simultaneous or sequential delivery of said pharmaceutical composition in the form of an aerosol or dry powder dispersion to said mammal, where said device is a metered dose inhaler or a dry powder inhaler. It is preferred that said dopamine D2-receptor agonist component be bromocriptine mesylate, naxagolide hydrochloride, cabergoline, pergolide mesylate, quinpirole hydrochloride, or ropinirole hydrochloride; and that said anti-cholinergic agent component be tiotropium bromide.
  • US5235055A
    申请人:——
    公开号:US5235055A
    公开(公告)日:1993-08-10
  • [EN] ANTIPSYCHOTIC QUINOLINE DERIVATIVES OF BENZODIOXANMETHYLAMINE<br/>[FR] DERIVES QUIOLINIQUES DE BENZODIOXANMETHYLAMINE NEUROLEPTIQUES
    申请人:——
    公开号:WO1994005655A1
    公开(公告)日:1994-03-17
    [EN] A compound of formula (1), wherein R1 and R2 are, independently, hydrogen, alkyl, alkoxy, aralkoxy, alkanoyloxy, hydroxy, halo, amino, mono- or dialkylamino, alkanamido or sulfonamido, or R1 and R2 together are methylenedioxy, ethylenedioxy or propylenedioxy; R3 is hydrogen or alkyl; n is one of the integers 2, 3 or 4; or a pharmaceutically acceptable salt thereof, are antipsychotic agents.
    [FR] Cette invention concerne un composé de formule (1) dans lequel R1 et R2 représentent indépendamment hydrogène, alkyle, alcoxy, aralcoxy, alcanoyloxy, hydroxy, halo, amino, mono- ou dialkylamino, alcanamido ou sulfonamido, ou bien R1 et R2 représentent ensemble méthylènedioxy, éthylènedioxy ou propylènedioxy; R3 représente hydrogène ou alkyle; et n représente un entier tel que 2, 3 ou 4. Ce composé ou un de ses sels pharmaceutiquement acceptable est un neuroleptique.
查看更多